Rogier Kersseboom

1.4k total citations
21 papers, 657 citations indexed

About

Rogier Kersseboom is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Rogier Kersseboom has authored 21 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Rogier Kersseboom's work include Immunodeficiency and Autoimmune Disorders (9 papers), Genetics and Neurodevelopmental Disorders (6 papers) and Immune Cell Function and Interaction (5 papers). Rogier Kersseboom is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (9 papers), Genetics and Neurodevelopmental Disorders (6 papers) and Immune Cell Function and Interaction (5 papers). Rogier Kersseboom collaborates with scholars based in Netherlands, United States and France. Rogier Kersseboom's co-authors include Rudi W. Hendriks, Sabine Middendorp, Esther A. Beuling, Steven T. Pals, David J. J. de Gorter, Marcel Spaargaren, Janine M. van Gils, Hassan Jumaa, Gemma M. Dingjan and Katarina Dahlenborg and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Immunity.

In The Last Decade

Rogier Kersseboom

19 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rogier Kersseboom Netherlands 13 281 280 205 152 130 21 657
Renée Beekman Netherlands 12 328 1.2× 253 0.9× 583 2.8× 225 1.5× 190 1.5× 20 1.1k
Amy Billet United States 7 169 0.6× 213 0.8× 127 0.6× 64 0.4× 45 0.3× 8 580
Sylwia Chocholska Poland 17 238 0.8× 231 0.8× 221 1.1× 119 0.8× 61 0.5× 55 692
N. Ghanem France 14 114 0.4× 292 1.0× 265 1.3× 49 0.3× 96 0.7× 46 756
Sakura Sakajiri Japan 14 106 0.4× 110 0.4× 358 1.7× 194 1.3× 73 0.6× 32 704
Takashi Akasaka Japan 15 229 0.8× 120 0.4× 222 1.1× 323 2.1× 25 0.2× 45 660
Maria Ciccone Italy 17 324 1.2× 259 0.9× 363 1.8× 173 1.1× 34 0.3× 45 818
Parham Ramezani-Rad United States 9 97 0.3× 263 0.9× 262 1.3× 57 0.4× 57 0.4× 19 615
Quangeng Zhang China 9 99 0.4× 229 0.8× 352 1.7× 163 1.1× 33 0.3× 12 747
Susan V. Outram United Kingdom 20 80 0.3× 283 1.0× 761 3.7× 127 0.8× 145 1.1× 26 1.0k

Countries citing papers authored by Rogier Kersseboom

Since Specialization
Citations

This map shows the geographic impact of Rogier Kersseboom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rogier Kersseboom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rogier Kersseboom more than expected).

Fields of papers citing papers by Rogier Kersseboom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rogier Kersseboom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rogier Kersseboom. The network helps show where Rogier Kersseboom may publish in the future.

Co-authorship network of co-authors of Rogier Kersseboom

This figure shows the co-authorship network connecting the top 25 collaborators of Rogier Kersseboom. A scholar is included among the top collaborators of Rogier Kersseboom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rogier Kersseboom. Rogier Kersseboom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Pellikaan, Karlijn, Anna G. W. Rosenberg, Rogier Kersseboom, et al.. (2021). Effects of Childhood Multidisciplinary Care and Growth Hormone Treatment on Health Problems in Adults with Prader-Willi Syndrome. Journal of Clinical Medicine. 10(15). 3250–3250. 11 indexed citations
4.
Pellikaan, Karlijn, Anna G. W. Rosenberg, Rogier Kersseboom, et al.. (2020). Missed Diagnoses and Health Problems in Adults With Prader-Willi Syndrome: Recommendations for Screening and Treatment. The Journal of Clinical Endocrinology & Metabolism. 105(12). e4671–e4687. 39 indexed citations
5.
Kersseboom, Rogier, et al.. (2018). Hemophilia B in a female with intellectual disability caused by a deletion of Xq26.3q28 encompassing the F9. Molecular Genetics & Genomic Medicine. 6(6). 1220–1224. 4 indexed citations
6.
Boogaard, Marlinde L. van den, Peter Thijssen, Caner Aytekin, et al.. (2017). Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2. Clinical Genetics. 92(4). 380–387. 36 indexed citations
7.
Veenbergen, Sharon, Gertjan J. Driessen, Rogier Kersseboom, et al.. (2017). Development and Function of Immune Cells in an Adolescent Patient With a Deficiency in the Interleukin‐10 Receptor. Journal of Pediatric Gastroenterology and Nutrition. 65(1). e5–e15. 11 indexed citations
8.
Houwing, Maite E., Rogier Kersseboom, Saskia L. Gooskens, et al.. (2015). Somatic thrombopoietin (THPO) gene mutations in childhood myeloid leukemias. International Journal of Hematology. 102(1). 140–143. 2 indexed citations
9.
Veenbergen, Sharon, Rogier Kersseboom, Lilian F. de Ruiter, et al.. (2013). 1 Functional consequences of a novel IL-10 receptor alpha mutation on innate and adaptive immunity in early-onset inflammatory bowel disease. Journal of Crohn s and Colitis. 7. S1–S1.
10.
Segers, Heidi, et al.. (2012). Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients. European Journal of Cancer. 48(17). 3249–3256. 43 indexed citations
11.
Kersseboom, Rogier, et al.. (2011). Educational paper. European Journal of Pediatrics. 170(3). 295–308. 14 indexed citations
12.
Kersseboom, Rogier, et al.. (2011). PTEN in colorectal cancer: a report on two Cowden syndrome patients. Clinical Genetics. 81(6). 555–562. 10 indexed citations
13.
Kersseboom, Rogier, Laurens P. Kil, Roelof Flierman, et al.. (2010). Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells. European Journal of Immunology. 40(9). 2643–2654. 21 indexed citations
14.
Bruijn, Marjolein J. W. de, Petra J. ter Brugge, Jan Piet van Hamburg, et al.. (2009). Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway. Blood. 115(7). 1385–1393. 14 indexed citations
15.
Gorter, David J. J. de, Esther A. Beuling, Rogier Kersseboom, et al.. (2007). Bruton's Tyrosine Kinase and Phospholipase Cγ2 Mediate Chemokine-Controlled B Cell Migration and Homing. Immunity. 26(1). 93–104. 230 indexed citations
16.
Kersseboom, Rogier, Andries Zijlstra, Sabine Middendorp, et al.. (2006). Bruton’s Tyrosine Kinase and SLP-65 Regulate Pre-B Cell Differentiation and the Induction of Ig Light Chain Gene Rearrangement. The Journal of Immunology. 176(8). 4543–4552. 29 indexed citations
17.
Hendriks, Rudi W. & Rogier Kersseboom. (2005). Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells. Seminars in Immunology. 18(1). 67–76. 16 indexed citations
18.
Middendorp, Sabine, Andries Zijlstra, Rogier Kersseboom, et al.. (2004). Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity. Blood. 105(1). 259–265. 42 indexed citations
19.
Kersseboom, Rogier, Sabine Middendorp, Gemma M. Dingjan, et al.. (2003). Bruton's Tyrosine Kinase Cooperates with the B Cell Linker Protein SLP-65 as a Tumor Suppressor in Pre-B Cells. The Journal of Experimental Medicine. 198(1). 91–98. 88 indexed citations
20.
Rosmalen, Judith G.M., et al.. (2001). Sex Steroids Influence Pancreatic Islet Hypertrophy and Subsequent Autoimmune Infiltration in Nonobese Diabetic (NOD) and NODscid Mice. Laboratory Investigation. 81(2). 231–239. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026